The Global Market for Cell and Tissue Culture Supplies is Projected to Reach US$8 Billion by 2024


Increasing Focus on Life Science, Biotechnology Research & Expanding Range of Applications Augur Well for Cell and Tissue Culture Supplies, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Cell and Tissue Culture Supplies market. The global market for Cell and Tissue Culture Supplies is projected to reach US$8 billion by 2024, driven by the growing use of cell culture techniques in diverse applications coupled with increasing R&D investments in cell and tissue culture.

Over the years, cell and tissue culture has emerged as a vital aspect of the life science research, offering a system for conducting research on various cell characteristics. The constant pace of advancements have positioned cell culture as an important tool in the field of cellular and molecular biology. Advancements in biotechnology and life science research coupled with expanding range of applications have been instrumental in driving growth in cell and tissue culture market. Cell culture experiments and processes typically involve the use of wide variety of instruments and supplies, which are used for growing and monitoring the cultures. A broad spectrum of cell and tissue culture supplies are used in labs for the purpose of growing cells for various applications including biological research and pharmaceutical development. Cell culture laboratories, pharmaceutical companies and biotechnology entities are the leading end-users of cell and tissue culture supplies.

Global market for cell and tissue culture supplies is forecast to post stable growth in the coming years, driven by the growing use of cell culture techniques in diverse applications such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering. The increasing prevalence of various chronic diseases and the steady increase in funding for research in the tissue engineering space augurs well for the cell and tissue culture supplies market. Demand for cell and tissue supplies is also being propelled by the sustained increase in demand for artificial organs and biopharmaceutical products across the world. Rising importance of cell culture technologies for producing therapeutics, biomolecules and traditional research is expected to stimulate growth in the cell culture supplies market. Also driving demand for cell and tissue culture supplies is the escalating demand for serum-free, customized media solutions. The market also benefits from the advent of new techniques of cell and tissue culture, which will spur demand for novel types of cell culture supplies. Rapid advancements in the cell culture space related to the development of a broad spectrum of therapeutic and bimolecular components are also fostering demand for cell and tissue culture supplies. The presence of several leading players offering a large portfolio of products including cell preservation and strategy, 3D cell proliferation, and stem tissue engineering, among others also impacts the global cell and tissue culture supplies market in a positive way.

As stated by the new market research report on Cell and Tissue Culture Supplies, the United States represents the largest market worldwide. Sustained technology advancements and increasing R&D investments in cell culture tools are driving growth in the US cell and culture tissue supplies market. Further, rising demand for automated cell culture systems and surging demand for media free from animal components are also influencing growth trends in the US. Asia-Pacific is forecast to register the fastest CAGR of 9.5% over the analysis period. The promising outlook of Asia-Pacific is credited to the growing trend towards outsourcing of biopharmaceutical industry operations to the region. Further, steady improvements in R&D investments and expanding infrastructure facilities in the region are also favoring the demand for cell and tissue culture supplies.

Major players in the market include Avantor Performance Materials LLC, BD Biosciences, BioIVT, Cell Culture Technologies, Corning Inc., GE Healthcare Life Sciences, Irvine Scientific Inc., Lonza Group AG, Merck Millipore, Sigma-Aldrich Corporation, SAFC Biosciences Inc., MP Biomedicals LLC, ORIGIO a/s, PromoCell GmbH, Thermo Fisher Scientific Inc., and Vitrolife AB, among others.

The research report titled “Cell and Tissue Culture Supplies Industry: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. The Cell and Tissue Culture Supplies Market is analyzed by the following Product Segments – Media, Sera and Reagents.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

Comments

Popular posts from this blog

The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The Global Market for Private Tutoring Services is Forecast to Reach US$227 Billion by 2022